Geoffrey A. Whynot will step down Sept. 30 as co-CEO and CFO of Medical Resources. Christopher J. Joyce, current co-CEO, will hold exclusive title to the job. Whynot will continue to serve as a consultant on special projects. Medical Resources operates
Geoffrey A. Whynot will step down Sept. 30 as co-CEO and CFO of Medical Resources. Christopher J. Joyce, current co-CEO, will hold exclusive title to the job. Whynot will continue to serve as a consultant on special projects. Medical Resources operates 60 imaging centers in the U.S. and provides network management services to managed care organizations in regions where its centers are concentrated.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.